| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-05 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.003 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.73 | 0.003 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.088 | 0.004 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.004 |